Constantine Davides
Stock Analyst at Citizens JMP
(0.10)
# 4,445
Out of 4,509 analysts
184
Total ratings
37.7%
Success rate
-12.2%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRC NRC Health | Initiated Coverage: Buy | $23 | $21.83 | +5.36% | 1 | Jun 22, 2026 | |
| HQY HealthEquity | Maintained: Buy | $122 → $111 | $95.66 | +16.04% | 9 | Jun 1, 2026 | |
| PGNY Progyny | Maintained: Buy | $30 → $31 | $31.98 | -3.06% | 8 | May 11, 2026 | |
| USPH U.S. Physical Therapy | Maintained: Buy | $113 → $98 | $71.59 | +36.89% | 6 | May 8, 2026 | |
| OMDA Omada Health | Maintained: Buy | $18 → $21 | $23.50 | -10.64% | 2 | May 8, 2026 | |
| CCRN Cross Country Healthcare | Downgraded: Hold | n/a | $13.22 | - | 11 | May 7, 2026 | |
| ADUS Addus HomeCare | Maintained: Buy | $150 → $142 | $108.86 | +30.44% | 8 | May 6, 2026 | |
| OPCH Option Care Health | Maintained: Buy | $38 → $32 | $21.70 | +47.47% | 17 | Apr 30, 2026 | |
| AMN AMN Healthcare Services | Maintained: Buy | $22 → $24 | $33.98 | -29.37% | 18 | Feb 23, 2026 | |
| WAY Waystar Holding | Maintained: Buy | $48 → $34 | $23.03 | +47.63% | 3 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $10 | $5.92 | +68.92% | 14 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $24 | $6.55 | +266.41% | 14 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $31 | $27.89 | +11.15% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $18.25 | - | 6 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.79 | n/a | 7 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $115.85 | n/a | 9 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $28.72 | n/a | 6 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $1.17 | n/a | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $0.356 | n/a | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $0.631 | n/a | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $45.99 | n/a | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $22.21 | n/a | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.25 | $1.65 | n/a | 2 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0001 | n/a | 3 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8.5 | $2.38 | n/a | 1 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.30 | n/a | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $2.43 | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $33 | $0.8619 | n/a | 3 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $68 | $1.30 | n/a | 1 | Oct 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $8 | $1.64 | n/a | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.25 | $2.34 | n/a | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.3 | $0.49 | n/a | 1 | Aug 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $1.77 | n/a | 1 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $58.36 | n/a | 1 | Sep 27, 2011 |
NRC Health
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $21.83
Upside: +5.36%
HealthEquity
Jun 1, 2026
Maintained: Buy
Price Target: $122 → $111
Current: $95.66
Upside: +16.04%
Progyny
May 11, 2026
Maintained: Buy
Price Target: $30 → $31
Current: $31.98
Upside: -3.06%
U.S. Physical Therapy
May 8, 2026
Maintained: Buy
Price Target: $113 → $98
Current: $71.59
Upside: +36.89%
Omada Health
May 8, 2026
Maintained: Buy
Price Target: $18 → $21
Current: $23.50
Upside: -10.64%
Cross Country Healthcare
May 7, 2026
Downgraded: Hold
Price Target: n/a
Current: $13.22
Upside: -
Addus HomeCare
May 6, 2026
Maintained: Buy
Price Target: $150 → $142
Current: $108.86
Upside: +30.44%
Option Care Health
Apr 30, 2026
Maintained: Buy
Price Target: $38 → $32
Current: $21.70
Upside: +47.47%
AMN Healthcare Services
Feb 23, 2026
Maintained: Buy
Price Target: $22 → $24
Current: $33.98
Upside: -29.37%
Waystar Holding
Feb 18, 2026
Maintained: Buy
Price Target: $48 → $34
Current: $23.03
Upside: +47.63%
Jan 6, 2026
Maintained: Buy
Price Target: $11 → $10
Current: $5.92
Upside: +68.92%
Nov 7, 2025
Maintained: Buy
Price Target: $23 → $24
Current: $6.55
Upside: +266.41%
Nov 7, 2025
Maintained: Buy
Price Target: $30 → $31
Current: $27.89
Upside: +11.15%
Jul 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $18.25
Upside: -
May 6, 2025
Maintained: Hold
Price Target: n/a
Current: $6.79
Upside: n/a
Apr 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $115.85
Upside: n/a
Feb 25, 2025
Maintained: Hold
Price Target: n/a
Current: $28.72
Upside: n/a
May 25, 2023
Initiated Coverage: Buy
Price Target: $18
Current: $1.17
Upside: n/a
May 16, 2023
Maintained: Buy
Price Target: $19
Current: $0.356
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $125
Current: $0.631
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $15
Current: $45.99
Upside: n/a
May 10, 2023
Reiterated: Buy
Price Target: $23
Current: $22.21
Upside: n/a
Apr 18, 2023
Reiterated: Buy
Price Target: $5.25
Current: $1.65
Upside: n/a
Mar 30, 2023
Reiterated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Mar 20, 2023
Initiated Coverage: Buy
Price Target: $8.5
Current: $2.38
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $6
Current: $1.30
Upside: n/a
Feb 15, 2023
Reiterated: Buy
Price Target: $15
Current: $2.43
Upside: n/a
Dec 30, 2022
Maintained: Buy
Price Target: $50 → $33
Current: $0.8619
Upside: n/a
Oct 18, 2022
Initiated Coverage: Buy
Price Target: $68
Current: $1.30
Upside: n/a
Sep 28, 2022
Maintained: Buy
Price Target: $14 → $8
Current: $1.64
Upside: n/a
Sep 23, 2022
Maintained: Buy
Price Target: $4.25
Current: $2.34
Upside: n/a
Aug 18, 2022
Maintained: Buy
Price Target: $2.3
Current: $0.49
Upside: n/a
Mar 14, 2022
Initiated Coverage: Buy
Price Target: $4
Current: $1.77
Upside: n/a
Sep 27, 2011
Initiated Coverage: Buy
Price Target: $41
Current: $58.36
Upside: n/a